Literature DB >> 23220153

Epac in cardiac calcium signaling.

Gema Ruiz-Hurtado1, Eric Morel, Alejandro Domínguez-Rodríguez, Anna Llach, Frank Lezoualc'h, Jean-Pierre Benitah, Ana M Gomez.   

Abstract

Epac, exchange protein directly activated by cAMP, is emerging as a new regulator of cardiac physiopathology. Although its effects are much less known than the classical cAMP effector, PKA, several studies have investigated the cardiac role of Epac, providing evidences that Epac modulates intracellular Ca(2+). In one of the first analyses, it was shown that Epac can increase the frequency of spontaneous Ca(2+) oscillations in cultured rat cardiomyocytes. Later on, in adult cardiomyocytes, it was shown that Epac can induce sarcoplasmic reticulum (SR) Ca(2+) release in a PKA independent manner. The pathway identified involved phospholipase C (PLC) and Ca(2+)/calmodulin kinase II (CaMKII). The latter phosphorylates the ryanodine receptor (RyR), increasing the Ca(2+) spark probability. The RyR, Ca(2+) release channel located in the SR membrane, is a key element in the excitation-contraction coupling. Thus Epac participates in the excitation-contraction coupling. Moreover, by inducing RyR phosphorylation, Epac is arrhythmogenic. A detailed analysis of Ca(2+) mobilization in different microdomains showed that Epac preferently elevated Ca(2+) in the nucleoplasm ([Ca(2+)]n). This effect, besides PLC and CaMKII, required inositol 1,4,5 trisphosphate receptor (IP3R) activation. IP3R is other Ca(2+) release channel located mainly in the perinuclear area in the adult ventricular myocytes, where it has been shown to participate in the excitation-transcription coupling (the process by which Ca(2+) activates transcription). If Epac activation is maintained for some time, the histone deacetylase (HDAC) is translocated out of the nucleus de-repressing the transcription factor myocyte enhancer factor (MEF2). These evidences also pointed to Epac role in activating the excitation-transcription coupling. In fact, it has been shown that Epac induces cardiomyocyte hypertrophy. Epac activation for several hours, even before the cell hypertrophies, induces a profound modulation of the excitation-contraction coupling: increasing the [Ca(2+)]i transient amplitude and cellular contraction. Thus Epac actions are rapid but time and microdomain dependent in the cardiac myocyte. Taken together the results collected indicate that Epac may have an important role in the cardiac response to stress.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220153     DOI: 10.1016/j.yjmcc.2012.11.021

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

1.  CaMKII mediates stimulus specificity in early odor preference learning in rats.

Authors:  Shirin Modarresi; Bandhan Mukherjee; John H McLean; Carolyn W Harley; Qi Yuan
Journal:  J Neurophysiol       Date:  2016-04-27       Impact factor: 2.714

Review 2.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 3.  Cardiac alternans and intracellular calcium cycling.

Authors:  Joshua N Edwards; Lothar A Blatter
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-07       Impact factor: 2.557

Review 4.  Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC).

Authors:  Haijun Chen; Christopher Wild; Xiaobin Zhou; Na Ye; Xiaodong Cheng; Jia Zhou
Journal:  J Med Chem       Date:  2013-11-27       Impact factor: 7.446

5.  Transforming growth factor β2 promotes transcription of COX2 and EP4, leading to a prostaglandin E2-driven autostimulatory loop that enhances virulence of Theileria annulata-transformed macrophages.

Authors:  Malak Haidar; Nadia Echebli; Ying Ding; Everlyn Kamau; Gordon Langsley
Journal:  Infect Immun       Date:  2015-02-17       Impact factor: 3.441

6.  Cross-Talk Between the Adenylyl Cyclase/cAMP Pathway and Ca2+ Homeostasis.

Authors:  Jose Sanchez-Collado; Jose J Lopez; Isaac Jardin; Gines M Salido; Juan A Rosado
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

7.  Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity.

Authors:  Stefan Neef; Jordi Heijman; Kristian Otte; Matthias Dewenter; Ali R Saadatmand; Stefanie Meyer-Roxlau; Christopher L Antos; Johannes Backs; Dobromir Dobrev; Michael Wagner; Lars S Maier; Ali El-Armouche
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-27       Impact factor: 3.000

Review 8.  Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems.

Authors:  Ivano Amelio; Vivien Landré; Richard A Knight; Andrey Lisitsa; Gerry Melino; Alexey V Antonov
Journal:  Oncotarget       Date:  2015

9.  Calcium/calmodulin-dependent kinase II and nitric oxide synthase 1-dependent modulation of ryanodine receptors during β-adrenergic stimulation is restricted to the dyadic cleft.

Authors:  Eef Dries; Demetrio J Santiago; Daniel M Johnson; Guillaume Gilbert; Patricia Holemans; Sanne M Korte; H Llewelyn Roderick; Karin R Sipido
Journal:  J Physiol       Date:  2016-07-03       Impact factor: 5.182

10.  Urocortin-1 Mediated Cardioprotection Involves XIAP and CD40-Ligand Recovery: Role of EPAC2 and ERK1/2.

Authors:  Eva Calderón-Sánchez; Ignacio Díaz; Antonio Ordóñez; Tarik Smani
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.